(Q40738550)
Statements
A phase II study of recombinant tumor necrosis factor in renal cell carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (English)
Skillings J
Wierzbicki R
Eisenhauer E
Venner P
Letendre F
Stewart D
1 January 1992